ZEVRA THERAPEUTICS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Zevra Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Zevra Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $123K, a 13.4% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $552K, a 5.75% increase from 2022.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $522K, a 13.5% increase from 2021.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $460K, a 2.91% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $552K +$30K +5.75% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $522K +$62K +13.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $460K +$13K +2.91% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $447K +$12K +2.76% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $435K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.